Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenoxicam vs Meloxicam for TMJ Disc Displacement
NCT06403046Phase 2Completed
- Sponsor
- Beni Suef University
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tenoxicam in temporomandibular joint disc displacement with reduction (2 arms), sponsored by Beni Suef University. Primary endpoints: Clicking at 9 months, Visual Analogue Scale at 9 months and 1 more. Started Jun 2024; status: completed.
02
Drugs
tenoxicam
03
Conditions
temporomandibular joint disc displacement with reduction
Beyond the preview
Go deeper on NCT06403046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06403046.